{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:49:49Z","timestamp":1787579389108,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canlet.2021.12.014","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T11:53:31Z","timestamp":1639655611000},"page":"140-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Drug repositioning: Using psychotropic drugs for the treatment of glioma"],"prefix":"10.1016","volume":"527","author":[{"given":"Fangting","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daofei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2021.12.014_bib1","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1002\/cam4.1757","article-title":"Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973-2014","volume":"7","author":"Li","year":"2018","journal-title":"Cancer Med-Us"},{"key":"10.1016\/j.canlet.2021.12.014_bib2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3389\/fgene.2019.01378","article-title":"OSgbm: an online consensus survival analysis web server for glioblastoma","volume":"10","author":"Dong","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.canlet.2021.12.014_bib3","first-page":"11","article-title":"Progression-free but No overall survival benefit for adult patients with bevacizumab therapy for the treatment of newly diagnosed glioblastoma: a systematic review and meta-analysis","author":"Kaka","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2021.12.014_bib4","doi-asserted-by":"crossref","first-page":"188616","DOI":"10.1016\/j.bbcan.2021.188616","article-title":"Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2021.12.014_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11912-017-0644-z","article-title":"Treatment of glioblastoma in older adults","volume":"19","author":"Braun","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.canlet.2021.12.014_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2018.00218","article-title":"Drug repositioning in glioblastoma: a pathway perspective","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2021.12.014_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2017.01.028","article-title":"Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics","volume":"1660","author":"Barygin","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.12.014_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.12.014_bib10","first-page":"595","article-title":"Implications of antipsychotic use: antipsychotic-induced movement disorders, with a focus on tardive dyskinesia","volume":"54","author":"Dilks","year":"2019","journal-title":"Nurs. Clin."},{"key":"10.1016\/j.canlet.2021.12.014_bib11","first-page":"CD011709","article-title":"Chlorpromazine versus piperacetazine for schizophrenia","volume":"10","author":"Eslami Shahrbabaki","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.canlet.2021.12.014_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1196\/annals.1414.041","article-title":"Potential inhibition of PDK1\/Akt signaling by phenothiazines suppresses cancer cell proliferation and survival","volume":"1138","author":"Choi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.canlet.2021.12.014_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-003-0738-1","article-title":"Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes - phenothiazines and leukemia","volume":"53","author":"Zhelev","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2021.12.014_bib14","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1158\/0008-5472.CAN-07-2235","article-title":"The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3858\/emm.2010.42.5.041","article-title":"Chlorpromazine activates p21Waf1\/Cip1 gene transcription via early growth response-1 (Egr-1) in C6 glioma cells","volume":"42","author":"Shin","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2021.12.014_bib16","article-title":"Hot papers - cell biology - the P21 cdk-interacting protein Cip1 is a potent inhibitor of 61 cyclin-dependent kinases","volume":"9","author":"Elledge","year":"1995","journal-title":"Comm. Sci."},{"key":"10.1016\/j.canlet.2021.12.014_bib17","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","article-title":"The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells","volume":"34","author":"Shin","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2021.12.014_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13046-021-02144-w","article-title":"Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response","volume":"40","author":"Matteoni","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib19","doi-asserted-by":"crossref","first-page":"635472","DOI":"10.3389\/fonc.2021.635472","article-title":"Anticancer properties of the antipsychotic drug chlorpromazine and its synergism with temozolomide in restraining human glioblastoma proliferation in vitro","volume":"11","author":"Matteoni","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib20","doi-asserted-by":"crossref","first-page":"37568","DOI":"10.18632\/oncotarget.17247","article-title":"Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit","volume":"8","author":"Oliva","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.12.014_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3928\/02793695-20151223-01","article-title":"Trifluoperazine: a sprightly old drug","volume":"54","author":"Howland","year":"2016","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"10.1016\/j.canlet.2021.12.014_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jcb.29892","article-title":"Calmodulin\/CaMKII-gamma mediates prosurvival capability in apicidin-persistent hepatocellular carcinoma cells via ERK1\/2\/CREB\/c-fos signaling pathway","volume":"122","author":"Hsu","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2021.12.014_bib23","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1002\/jcb.26848","article-title":"Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells","volume":"119","author":"Fancy","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2021.12.014_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejmech.2018.03.055","article-title":"Repositioning of the antipsychotic trifluoperazine: synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents","volume":"151","author":"Kang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2021.12.014_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbrc.2020.01.073","article-title":"Interaction between IDH1 WT and calmodulin and its implications for glioblastoma cell growth and migration","volume":"524","author":"Kang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2021.12.014_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fonc.2019.00118","article-title":"Glioblastoma stem-like cells, metabolic strategy to kill a challenging target","volume":"9","author":"Garnier","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib27","doi-asserted-by":"crossref","first-page":"111058","DOI":"10.1016\/j.biopha.2020.111058","article-title":"Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells","volume":"133","author":"Datta","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2021.12.014_bib28","first-page":"3300","article-title":"Trifluoperazine prevents FOXO1 nuclear excretion and reverses doxorubicin-resistance in the SHG44\/DOX drug-resistant glioma cell line","volume":"42","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2021.12.014_bib29","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1073\/pnas.1920154117","article-title":"The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma","volume":"117","author":"Bhat","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.12.014_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mrgentox.2007.05.011","article-title":"Trifluoperazine stimulates ionizing radiation induced cell killing through inhibition of DNA repair","volume":"633","author":"Gangopadhyay","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/1097-0142(19820315)49:6<1178::AID-CNCR2820490619>3.0.CO;2-H","article-title":"Effects of dopamine agonists and antagonists on murine melanoma: correlation with dopamine binding activity","volume":"49","author":"Krummel","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2021.12.014_bib32","series-title":"Repurposing Antipsychotics of the Diphenylbutylpiperidine Class for Cancer Therapy","author":"Shaw","year":"2019"},{"key":"10.1016\/j.canlet.2021.12.014_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3892\/ijo.2015.3229","article-title":"The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation","volume":"48","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib34","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1158\/0008-5472.CAN-18-1357","article-title":"ID1 is critical for tumorigenesis and regulates chemoresistance in glioblastoma","volume":"79","author":"Sachdeva","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib35","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1541-7786.MCR-18-0125","article-title":"EGFRvIII-Stat5 signaling enhances glioblastoma cell migration and survival","volume":"16","author":"Roos","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000502562","article-title":"The dopamine D2 receptor contributes to the spheroid formation behavior of U87 glioblastoma cells","volume":"105","author":"Weissenrieder","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.canlet.2021.12.014_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1476-5381.2010.00923.x","article-title":"Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines","volume":"161","author":"Kast","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.canlet.2021.12.014_bib38","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/brain\/awaa408","article-title":"Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma","volume":"144","author":"Hong","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.canlet.2021.12.014_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/nov091","article-title":"USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance","volume":"18","author":"Lee","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib40","first-page":"1","article-title":"Autophagy activation, lipotoxicity and lysosomal membrane permeabilization synergize to promote pimozide- and loperamide-induced glioma cell death","author":"Meyer","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2021.12.014_bib41","first-page":"413","article-title":"The emerging role of m-TOR up-regulation in brain Astrocytoma","volume":"32","author":"Ryskalin","year":"2017","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.canlet.2021.12.014_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11864-020-0704-8","article-title":"Nausea and vomiting in advanced cancer","volume":"21","author":"Navari","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib43","first-page":"6177","article-title":"Olanzapine, an atypical antipsychotic, inhibits survivin expression and sensitizes cancer cells to chemotherapeutic agents","volume":"37","author":"Sanomachi","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-014-1688-7","article-title":"Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect","volume":"122","author":"Karpel-Massler","year":"2015","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/cns.13127","article-title":"Olanzapine induced autophagy through suppression of NF-kappaB activation in human glioma cells","volume":"25","author":"Zhu","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.canlet.2021.12.014_bib46","article-title":"The radiosensitizing effect of olanzapine as an antipsychotic medication in glioblastoma cell","author":"Allahgholipour","year":"2021","journal-title":"Curr. Rad."},{"key":"10.1016\/j.canlet.2021.12.014_bib47","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00280-017-3329-2","article-title":"Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme","volume":"79","author":"Bielecka-Wajdman","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2021.12.014_bib48","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/0895-4356(95)00545-5","article-title":"Do antidepressants cause, promote, or inhibit cancers","volume":"48","author":"Steingart","year":"1995","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.canlet.2021.12.014_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s12276-020-0389-x","article-title":"New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells","volume":"52","author":"Alburquerque-Gonzalez","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2021.12.014_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2867-11-6","article-title":"The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line","volume":"11","author":"Asher","year":"2011","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2021.12.014_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbrc.2011.08.093","article-title":"The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells","volume":"413","author":"Jeon","year":"2011","journal-title":"Biochem. Bioph. Res. Co."},{"key":"10.1016\/j.canlet.2021.12.014_bib52","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1111\/jcmm.15022","article-title":"Induction of apoptosis through extrinsic\/intrinsic pathways and suppression of ERK\/NF-kappaB signalling participate in anti-glioblastoma of imipramine","volume":"24","author":"Hsu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2021.12.014_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.16874","article-title":"Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide","author":"Wang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2021.12.014_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-200161010-00010","article-title":"Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness","volume":"61","author":"Cheer","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.canlet.2021.12.014_bib55","doi-asserted-by":"crossref","first-page":"110054","DOI":"10.1016\/j.biopha.2020.110054","article-title":"Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model","volume":"126","author":"Hsu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2021.12.014_bib56","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.21873\/anticanres.13823","article-title":"Fluoxetine enhances anti-tumor activity of paclitaxel in gastric adenocarcinoma cells by triggering apoptosis and necroptosis","volume":"39","author":"Khing","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib57","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/1535370213493721","article-title":"Antidepressant drugs as a complementary therapeutic strategy in cancer","volume":"238","author":"Bielecka","year":"2013","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.canlet.2021.12.014_bib58","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.18632\/oncotarget.13689","article-title":"The antidepressant fluoxetine induces necrosis by energy depletion and mitochondrial calcium overload","volume":"8","author":"Charles","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.12.014_bib59","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/or.2016.4860","article-title":"Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells","volume":"36","author":"Ma","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2021.12.014_bib60","first-page":"2199","article-title":"Disruption of NF-kappaB signaling by fluoxetine attenuates MGMT expression in glioma cells","volume":"8","author":"Song","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2021.12.014_bib61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10863-020-09833-9","article-title":"Fluoxetine as an antidepressant medicine improves the effects of ionizing radiation for the treatment of glioma","volume":"52","author":"Hosseinimehr","year":"2020","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.canlet.2021.12.014_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.08.018","article-title":"Monoamine NMDA receptor channel blockers inhibit and potentiate native and recombinant proton-gated ion channels","volume":"89","author":"Tikhonova","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.canlet.2021.12.014_bib63","first-page":"3","article-title":"Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy","author":"Jiang","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2021.12.014_bib64","first-page":"277","article-title":"Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice","volume":"33","author":"Gil-Ad","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib65","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1248\/bpb.b15-00128","article-title":"Comparison of the anti-tumor effects of selective serotonin reuptake inhibitors as well as serotonin and norepinephrine reuptake inhibitors in human hepatocellular carcinoma cells","volume":"38","author":"Kuwahara","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.canlet.2021.12.014_bib66","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/neuonc\/not111","article-title":"Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions","volume":"15","author":"Schmidt","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib67","first-page":"1043","article-title":"In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells","volume":"37","author":"Tzadok","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib68","doi-asserted-by":"crossref","first-page":"502","DOI":"10.18632\/oncotarget.969","article-title":"A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care","volume":"4","author":"Kast","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.12.014_bib69","doi-asserted-by":"crossref","first-page":"8052","DOI":"10.18632\/oncotarget.2408","article-title":"CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide","volume":"5","author":"Kast","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.12.014_bib70","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.18632\/oncotarget.26994","article-title":"Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: a comprehensive review","volume":"10","author":"Kamarudin","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.12.014_bib71","doi-asserted-by":"crossref","first-page":"23372","DOI":"10.1038\/srep23372","article-title":"Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization","volume":"6","author":"Hayashi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2021.12.014_bib72","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ncb1626","article-title":"Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2\/3 complex","volume":"9","author":"Serrels","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2021.12.014_bib73","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nn.3351","article-title":"mTORC2 controls actin polymerization required for consolidation of long-term memory","volume":"16","author":"Huang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.canlet.2021.12.014_bib74","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1158\/0008-5472.CAN-13-3540","article-title":"Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling","volume":"74","author":"van Noort","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.12.014_bib75","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3389\/fphar.2019.01262","article-title":"Surprising anticancer activities of psychiatric medications: old drugs offer new hope for patients with brain cancer","volume":"10","author":"Zhuo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2021.12.014_bib76","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/jcmm.13372","article-title":"Escitalopram oxalate induces apoptosis in U-87MG cells and autophagy in GBM8401 cells","volume":"22","author":"Chen","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2021.12.014_bib77","doi-asserted-by":"crossref","first-page":"42789","DOI":"10.18632\/oncotarget.17050","article-title":"Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation","volume":"8","author":"Sakka","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.12.014_bib78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.mcn.2017.10.005","article-title":"Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes","volume":"85","author":"Maffioletti","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.canlet.2021.12.014_bib79","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/13543784.2012.694425","article-title":"Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results","volume":"21","author":"Berendsen","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.canlet.2021.12.014_bib80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-011-1085-x","article-title":"VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin","volume":"361","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2021.12.014_bib81","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00432-015-2020-4","article-title":"Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4","volume":"142","author":"Lan","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1471-4159.2002.01081.x","article-title":"Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase","volume":"83","author":"Bacon","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.canlet.2021.12.014_bib83","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/neuonc\/nop005","article-title":"Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines","volume":"12","author":"Fu","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib84","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720981878","article-title":"Valproic acid enhanced apoptosis by promoting autophagy via akt\/mTOR signaling in glioma","volume":"29","author":"Han","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.canlet.2021.12.014_bib85","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2176\/nmc.52.186","article-title":"Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain","volume":"52","author":"Osuka","year":"2012","journal-title":"Neurol. Med.-Chir."},{"key":"10.1016\/j.canlet.2021.12.014_bib86","doi-asserted-by":"crossref","first-page":"722754","DOI":"10.3389\/fonc.2021.722754","article-title":"Valproic acid enhanced temozolomide-induced anticancer activity in human glioma through the p53-PUMA apoptosis pathway","volume":"11","author":"Tsai","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib87","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00432-019-03118-4","article-title":"Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes","volume":"146","author":"Kiweler","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-011-0725-z","article-title":"Valproic acid sensitizes human glioma cells for temozolomide and gamma-radiation","volume":"107","author":"Van Nifterik","year":"2012","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11060-008-9662-x","article-title":"Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma","volume":"90","author":"Wolff","year":"2008","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28283","article-title":"A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma","volume":"67","author":"Su","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2021.12.014_bib91","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3892\/ijo.2015.2911","article-title":"Lithium chloride induces mesenchymaltoepithelial reverting transition in primary colon cancer cell cultures","volume":"46","author":"Costabile","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib92","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcp.2008.09.026","article-title":"Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells","volume":"77","author":"Beurel","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2021.12.014_bib93","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1215\/15228517-2008-041","article-title":"Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3","volume":"10","author":"Nowicki","year":"2008","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2021.12.014_bib94","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/bjc.2017.89","article-title":"Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1\/FasL signalling","volume":"116","author":"Han","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2021.12.014_bib95","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2021.12.014_bib96","article-title":"Glioma-induced peritumoral hyperexcitability in a pediatric glioma model","volume":"8","author":"Chaunsali","year":"2020","journal-title":"Phys. Rep."},{"key":"10.1016\/j.canlet.2021.12.014_bib97","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nn.4088","article-title":"EAG2 potassium channel with evolutionarily conserved function as a brain tumor target","volume":"18","author":"Huang","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.canlet.2021.12.014_bib98","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1085\/jgp.200409041","article-title":"Mechanism of block of hEag1 K+ channels by imipramine and astemizole","volume":"124","author":"Garcia-Ferreiro","year":"2004","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.canlet.2021.12.014_bib99","first-page":"8","volume":"F1000Res","author":"Buracco","year":"2019"},{"key":"10.1016\/j.canlet.2021.12.014_bib100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-016-0338-2","article-title":"CRM1\/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways","volume":"9","author":"Liu","year":"2016","journal-title":"J. Hematol. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521006273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521006273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:02:24Z","timestamp":1759593744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521006273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":100,"alternative-id":["S0304383521006273"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.12.014","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repositioning: Using psychotropic drugs for the treatment of glioma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}